CAITLIN SCHUBMEHL: Open Payments
NPI 1205460243 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$857 in 28 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $274 · 2025 $857
Food & beverage: $857
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $290 |
| Phathom Pharmaceuticals, Inc. | 1 | $149 |
| Lilly USA, LLC | 4 | $130 |
| GENZYME CORPORATION | 1 | $123 |
| ABBVIE INC. | 4 | $106 |
| Gilead Sciences, Inc. | 3 | $59 |
Products named: TREMFYA, VOQUEZNA, OMVOH, DUPIXENT, RINVOQ, LINZESS.
Industry payments across CA — which companies pay providers there.
